Clinical Trials Directory

Trials / Unknown

UnknownNCT04440683

Antler Plate on Preventing Mammary High-risk Lesions From Malignant Development

Status
Unknown
Phase
Study type
Observational
Enrollment
6,000 (estimated)
Sponsor
Jilin University · Academic / Other
Sex
Female
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This study aims to prove whether antler disk extract can be put into clinical practice to prevent breast precancerous lesions from developing into cancer.

Detailed description

Through estrogen receptor antagonists, tamoxifen can reduce the risk of breast high-risk disease progression to cancer, but only reduce the probability of some ER and PR positive tumors, which has no preventive effect on triple negative breast cancer and HER-2 positive breast cancer. In the first hospital of Jilin University, the preparations containing antler ingredients have been clinically proven to be able to treat breast hyperplasia, which has been proved to be able to prevent breast cancer in basic research, and antler ingredients have been proved to be non-toxic and side effects in the treatment dose. This study aims to prove whether antler disk extract can be put into clinical practice to prevent breast precancerous lesions from developing into cancer.

Conditions

Timeline

Start date
2020-06-01
Primary completion
2022-05-01
Completion
2025-06-01
First posted
2020-06-22
Last updated
2020-06-22

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04440683. Inclusion in this directory is not an endorsement.

Antler Plate on Preventing Mammary High-risk Lesions From Malignant Development (NCT04440683) · Clinical Trials Directory